Severe Outcomes From COVID-19 Up With Preexisting Neuropsych Conditions

WEDNESDAY, Nov. 16, 2022 (HealthDay News) -- People with neuropsychiatric conditions and/or associated treatment have an increased risk for severe outcomes from COVID-19 and from other severe acute respiratory infections (SARIs), according to a study published online Nov. 9 in JAMA Psychiatry.
Tom Alan Ranger, Ph.D., from the University of Oxford in the United Kingdom, and colleagues examined whether neuropsychiatric conditions are associated with severe outcomes from COVID-19 infection and other SARIs in prepandemic (2015 to 2020) and contemporary (2020 to 2021) longitudinal cohorts (11,134,789 adults [223,569 SARI cases] and 8,388,956 adults [58,203 severe COVID-19 cases], respectively).
The researchers observed an association for diagnosis and/or treatment for neuropsychiatric conditions other than dementia with an increased likelihood of a severe outcome from SARI (hazard ratios, 1.16 and 2.56 for anxiety diagnosis and psychotic disorder diagnosis and treatment, respectively) and COVID-19 (hazard ratios, 1.16 and 2.37 for anxiety diagnosis and psychotic disorder treatment, respectively). Compared with SARI, those with COVID-19 had a higher effect estimate for severe outcome with dementia (hazard ratio, 2.85 versus 2.13).
"The adjusted results comparing severe outcomes from COVID-19 disease and other SARI largely seemed similar, suggesting that the associations were not disease specific," the authors write. "Although dementia was associated with a higher increased risk of severe outcome from COVID-19 than for SARI, well-documented impacts of the pandemic on specific care settings mean that this result should be interpreted with caution."
Several authors disclosed financial ties to industry.
Related Posts
Tomar medicamentos para el TDAH no aumenta el riesgo de abuso de drogas en el futuro de un niño: estudio
JUEVES, 6 de julio de 2023 (HealthDay News) -- Los medicamentos estimulantes,...
Las personas mayores que viven a favor del viento de los sitios de fractura hidráulica viven menos: estudio
VIERNES, 28 de junio de 2022 (HealthDay News) -- Las personas mayores que viven...
Adverse Association Identified for Calcium Channel Blocker Use, Glaucoma
FRIDAY, Sept. 8, 2023 (HealthDay News) -- There is an adverse association...
ASCO: Adding Pembrolizumab to Chemo Improves Survival in Cervical Cancer
THURSDAY, June 1, 2023 (HealthDay News) -- For women with persistent, recurrent,...